Real World Data (RWD) and Real World Evidence (RWE) are gaining traction across the industry. The front runners are already exploring new ways to collect and use data within their market access strategies and, for some, this is proving an effective way to ‘tip the balance’ from a no to a yes with target agencies. How well is pharma leveraging the data advantage? And how should companies benchmark their own RWD activities against the best of the rest? This FirstWord report is now available for purchase, here. (Source: FirstWord, March 2017)
You are here: / / How Well is the Pharma Industry Utilizing RWE?